Key result
Serum adiponectin concentration decreases in higher stages of hepatic fibrosis across the entire clinicopathologic spectrum of nonalcoholic fatty liver disease.
Serum adiponectin concentration decreases in higher stages of hepatic fibrosis in NAFLD.
Adiponectin should not guide NAFLD fibrosis assessment yet; leaves open its biomarker role pending prospective validation.
4th Department of Internal Medicine Medical School of Aristotle University of Thessaloniki, Hippocration General Hospital of ThessalonikiThessaloniki, Greece The author declare no grants or financial support. The author declare no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Savvoula Savvidou (2010) studied this question. Serum adiponectin concentration decreases in higher stages of hepatic fibrosis across the entire clinicopathologic spectrum of nonalcoholic fatty liver disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: